Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedAdvisor Limited ( (AU:MDR) ) has provided an announcement.
MedAdvisor Limited announced the cessation of Kevin Hutchinson as a director, effective August 29, 2025. As part of this announcement, it was disclosed that Hutchinson held 2,000,000 unlisted options and 393,943 fully paid ordinary shares. This change in directorship may influence the company’s strategic direction and stakeholder confidence.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital medication management solutions. The company focuses on improving patient outcomes by offering services that streamline the process of managing prescriptions and medication adherence.
Average Trading Volume: 974,172
Technical Sentiment Signal: Sell
Current Market Cap: A$35.01M
Learn more about MDR stock on TipRanks’ Stock Analysis page.